FNMAL vs KYMR
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
FNMAL · FEDERAL NATIONAL MORTGAGE ASSOC 4.75% PRF SER'M' USD50$9.75 ▲ 1.04%
KYMR · Kymera Therapeutics$131.73 ▲ 2.82%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- FNMAL -60.2%
- KYMR +115.0%
Head to head
| Metric | FNMAL | KYMR |
|---|---|---|
| Price | $9.75 | $131.73 |
| Change today | ▲ 1.04% | ▲ 2.82% |
| Market cap | $11.23B | $11.25B |
| Return, 3 months | -27.7% | +21.3% |
| Return, year to date | -55.0% | +69.3% |
| Return, 1 year | -60.2% | +124.6% |
| P/E (TTM) | 1,392.9 | – |
| P/B | -2.8 | 7.0 |
| P/E percentile vs own 5y | – | 3rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -100.0% |
| Net profit growth (YoY) | – | -60.6% |
| Gross margin | – | – |
| Operating margin | – | -396.0% |
| Net margin | – | -341.8% |
| Return on equity | – | -27.3% |
| Analyst target vs. price | – | +9.2% |
| Analyst buy share | – | 94% |
| RSI (14) | 42 | 65 |
| 30-day volatility | 53.4% | 46.3% |
| Max drawdown, 1 year | -63.3% | -27.7% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- KYMR is the largest of the group by market value.
- KYMR has returned the most over the past year.
- KYMR has been the calmest stock over the last 30 days.